Literature DB >> 9256478

Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty.

D Panda1, G C Kundu, B I Lee, A Peri, D Fohl, I Chackalaparampil, B B Mukherjee, X D Li, D C Mukherjee, S Seides, J Rosenberg, K Stark, A B Mukherjee.   

Abstract

Angioplasty procedures are increasingly used to reestablish blood flow in blocked atherosclerotic coronary arteries. A serious complication of these procedures is reocclusion (restenosis), which occurs in 30-50% of patients. Migration of coronary artery smooth muscle cells (CASMCs) to the site of injury caused by angioplasty and subsequent proliferation are suggested mechanisms of reocclusion. Using both cultured human CASMCs and coronary atherectomy tissues, we studied the roles of osteopontin (OPN) and one of its receptors, alphavbeta3 integrin, in the pathogenesis of coronary restenosis. We also measured the plasma levels of OPN before and after angioplasty and determined the effect of exogenous OPN on CASMC migration, extracellular matrix invasion, and proliferation. We found that cultured CASMCs during log phase of growth and smooth muscle cell layer of the coronary atherosclerotic tissues of patients express both OPN mRNA and protein at a significantly elevated level compared with controls. Interestingly, whereas the baseline plasma OPN levels in control samples were virtually undetectable, those in patient plasma were remarkably high. We also found that interaction of OPN with alphavbeta3 integrin, expressed on CASMCs, causes migration, extracellular matrix invasion, and proliferation. These effects were abolished when OPN or alphavbeta3 integrin gene expression in CASMCs was inhibited by specific antisense S-oligonucleotide treatment or OPN-alphavbeta3 interaction was blocked by treatment of CASMCs with antibodies against OPN or alphavbeta3 integrin. Our results demonstrate that OPN and alphavbeta3 integrin play critical roles in regulating cellular functions deemed essential for restenosis. In addition, these results raise the possibility that transient inhibition of OPN gene expression or blocking of OPN-alphavbeta3 interaction may provide a therapeutic approach to preventing restenosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256478      PMCID: PMC23171          DOI: 10.1073/pnas.94.17.9308

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.

Authors:  D R Senger; C A Perruzzi
Journal:  Biochim Biophys Acta       Date:  1996-11-08

4.  Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro.

Authors:  L Liaw; M Almeida; C E Hart; S M Schwartz; C M Giachelli
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

5.  Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty.

Authors:  G E Austin; N B Ratliff; J Hollman; S Tabei; D F Phillips
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

6.  Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.

Authors:  T Ikeda; T Shirasawa; Y Esaki; S Yoshiki; K Hirokawa
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Influence of an intermittent compressive force on matrix protein expression by ROS 17/2.8 cells, with selective stimulation of osteopontin.

Authors:  T Kubota; M Yamauchi; J Onozaki; S Sato; Y Suzuki; J Sodek
Journal:  Arch Oral Biol       Date:  1993-01       Impact factor: 2.633

8.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

Authors:  D R Senger; S R Ledbetter; K P Claffey; A Papadopoulos-Sergiou; C A Peruzzi; M Detmar
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 9.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

10.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

Authors:  L Liaw; M P Skinner; E W Raines; R Ross; D A Cheresh; S M Schwartz; C M Giachelli
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  27 in total

1.  Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.

Authors:  Philipp Stawowy; Kristof Graf; Stephan Goetze; Mattias Roser; Michel Chrétien; Nabil G Seidah; Eckart Fleck; Mieczyslaw Marcinkiewicz
Journal:  Histochem Cell Biol       Date:  2003-02-20       Impact factor: 4.304

2.  Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane.

Authors:  Lea Scheppke; Eric A Murphy; Alessandro Zarpellon; Jennifer J Hofmann; Alona Merkulova; David J Shields; Sara M Weis; Tatiana V Byzova; Zaverio M Ruggeri; M Luisa Iruela-Arispe; David A Cheresh
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

3.  Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.

Authors:  Gábor Valcz; Ferenc Sipos; Tibor Krenács; Jeannette Molnár; Arpád V Patai; Katalin Leiszter; Kinga Tóth; Norbert Solymosi; Orsolya Galamb; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2010-03-27       Impact factor: 3.201

4.  Different profile of endothelial cell apoptosis in patients with Klinefelter's syndrome.

Authors:  R A Condorelli; A E Calogero; S La Vignera
Journal:  J Endocrinol Invest       Date:  2012-03-06       Impact factor: 4.256

5.  Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

6.  PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress.

Authors:  Joshua K Salabei; Timothy D Cummins; Mahavir Singh; Steven P Jones; Aruni Bhatnagar; Bradford G Hill
Journal:  Biochem J       Date:  2013-05-01       Impact factor: 3.857

7.  Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.

Authors:  Mansoor Ahmed; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-05-07       Impact factor: 27.401

8.  Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.

Authors:  Priyanka Sharma; Santosh Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

9.  Featured article: induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration.

Authors:  Joseph Fomusi Ndisang; Shuchita Tiwari
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-22

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.